| || |
|Page 1 of 1 || Previous | Next |
| || | DIABETES HEALTH
MAY 16, 2012 [Biphasic Insulin] Taiwanese Study Identifies Top Three Drugs for Type 2 Glycemic Control
Researchers in Taipei, Taiwan, report that they have identified the top three drugs for reducing A1C levels in type 2 diabetes: biphasic insulin, GLP-1 analogs, and basal insulin. They hedged a little on their endorsement of GLP-1 analogs, however, by saying that although they are not decisively better at controlling A1Cs than other oral diabetes drugs, they have the advantage of helping to reduce weight without adding to the danger of hypoglycemia
| || | DIABETES IN CONTROL
FEBRUARY 3, 2009 [Biphasic Insulin] Recent Advances in GLP-1 Receptor Agonists in the Treatment of.
Incretin Mimetics During an oral session entitled "GLP-1 Based Therapies," data were presented comparing the addition of liraglutide, a long-acting human GLP-1 receptor agonist, with the addition of insulin glargine to the therapeutic regimens of patients whose diabetes was poorly controlled with metformin-sulfonylurea combination therapy. Another study investigated exenatide alone and in combination with metformin in obese insulin-resistant women with polycystic ovary syndrome.